scorecardresearch
Add as a preferred source on Google
Wednesday, December 17, 2025
TopicBharat Biotech

Topic: Bharat Biotech

Tackling India’s vaccine hesitancy, and Modi’s ‘world topper’ trophy

The best cartoons of the day, chosen by the editors at ThePrint.

After Congress’ Jairam & Tharoor, now Milind Deora questions ‘speedy’ approval for Covaxin

Milind Deora joins Shashi Tharoor and Jairam Ramesh in questioning ‘premature approval’ for Bharat Biotech’s Covaxin even though the Congress has officially welcomed the vaccine.

Those doubting Bharat Biotech’s efficacy mentally challenged, says Union minister Pradhan

Dharmendra Pradhan's remarks came after Congress leaders raised doubts on the approval of Bharat Biotech's vaccine, for restricted use, while its 3rd phase trial is still underway.

Thank you, Akhilesh Yadav. BJP can take its vaccine nationalism from here

Samajwadi Party chief Akhilesh Yadav erred big time with his ‘BJP’s vaccine’ comment. But it highlights how BJP is winning the battle of public perception in Covid management.

Submit Covaxin safety reports every 15 days, include mild side-effects — govt to Bharat Biotech

Drug regulator DCGI’s approval to Bharat Biotech’s Covaxin for emergency use is subject to certain conditions detailed in the ‘permission form’.

Congress questions why Bharat Biotech’s Covaxin was cleared without completing phase-3 trials

Congress’ Anand Sharma, head of parliamentary panel, says health ministry needs to explain sidestepping protocol because Covaxin will be given to frontline workers.

Covaxin approved as it’s more likely to act against mutant Covid strain, says ICMR chief

In an interview, ICMR chief Balram Bhargava addressed questions that have been raised about the approval granted to Covaxin in the absence of efficacy data.

Covaxin & Covishield get govt nod for emergency use, stage set for Covid immunisation to begin

Drugs Controller General of India has granted 'conditional approval' to the vaccine candidates. A third candidate by Cadila Healthcare has got nod to conduct Phase III clinical trial.

Bharat Biotech’s Covaxin given conditional nod based on incomplete Phase 3 trial results data

Covaxin has been recommended for restricted emergency use authorisation by a subject expert committee appointed by the Central Drugs Standard Control Organisation.

Everything you need to know about Covaxin, India’s controversial Covid vaccine candidate

Bharat Biotech's Covaxin has been recommended for restricted emergency use authorisation by an expert committee appointed by the Central Drugs Standard Control Organisation.

On Camera

Who grounded IndiGo flights? They are the culprits, not DGCA

The IndiGo crisis is nothing short of a threat to India’s stability. Could it be an experiment? Can this happen in any other crucial sector like power or railways?

Steady growth rooted in ‘Dravidian model’. How Tamil Nadu more than doubled its GSDP in 10 yrs

RBI Handbook of Statistics shows state’s GSDP has more than doubled in past decade, finishing second behind Maharashtra. It has performed well across health & education parameters as well.

Israel has ‘realised who its real friend is’, eyes defence expansion in India amid arms curbs by others

It is argued that India-Israel ties are moving from buyer–seller dynamic to one focused on joint development & manufacturing partnership, a shift 'more durable' than traditional arms sales.

India’s top airline just handed sarkar the keys. That’s IndiGo’s real ‘crime’

Don’t blame misfortune. This is colossal incompetence and insensitivity. So bad, heads would have rolled even in the old PSU-era Indian Airlines and Air India.